AUSTAR (06118) released its interim performance results, with a net profit attributable to shareholders of 24.99 million yuan, an increase of 325.37% year-on-year.
Ostar Life Science and Technology (06118) announced its interim results for the six months ended June 30, 2025, with revenue of 6....
AUSTAR (06118) released its interim financial results for the six months ended June 30, 2025. The revenue was 662 million yuan (RMB, the same below), a decrease of 5.57% year-on-year; the net profit attributable to shareholders was 24.999 million yuan, an increase of 325.37% year-on-year; and the basic earnings per share were 0.05 yuan.
Related Articles
US Stock Market Move | "The most important stock on earth" NVIDIA Corporation (NVDA.US) is about to announce its second quarter earnings. The stock price rose nearly 1% in intraday trading.
US Stock Market Move | Chip stocks rose slightly, with AMD (AMD.US) up more than 1.3%.
US Stock Market Move | Femasys (FEMY.US) stock price plummets 37%, hitting a new low for the year.
US Stock Market Move | "The most important stock on earth" NVIDIA Corporation (NVDA.US) is about to announce its second quarter earnings. The stock price rose nearly 1% in intraday trading.
US Stock Market Move | Chip stocks rose slightly, with AMD (AMD.US) up more than 1.3%.
US Stock Market Move | Femasys (FEMY.US) stock price plummets 37%, hitting a new low for the year.
RECOMMEND
Analysts Respond to Trump’s Dismissal of Fed Governor Cook as a Further Assault on Central Bank Independence
26/08/2025
U.S. Proposes Including Copper, Silicon, Silver on 2025 Critical Minerals List Amid Supply Chain Concerns
26/08/2025
Trump Vows to Slash U.S. Drug Prices by Up to 1500%, Triggering Sell-Off in Pharma Stocks
26/08/2025
